Fever associated with malignancies might be the result of EP production by neoplastic cells themselves. Alternatively, host mononuclear or polymorphonuclear leukocytes may be stimulated to release EP by factors released by tumor cells, or generated by other host cells in response to tumor growth. In previous studies, abnormal, spontaneous EP production was demonstrated in cell suspensions prepared from spleen and lymph nodes of patients with Hodgkin's disease (8) , but the cell type(s) responsible for this production were not identified. We have now investigated release of EP by neoplastic cell lines in vitro, including six mouse tumor lines having the characteristics of leukemia or lymphoma cells, three carcinoma lines of human origin, and one viral-transformed mouse fibroblast line. Spontaneous EP release has been documented from five of the six mouse tumor cell lines.
Materials and Methods
All materials, glassware, and reagents were obtained or made sterile and pyrogen-free by methods described previously (9) . All test supernates were centrifuged at 800-2,000 g for [10] [11] [12] [13] [14] [15] min and cultured in thioglycollate broth before injection; any contaminated samples were discarded.
Pyrogen Assay. Culture supernates were tested for pyrogenicity using a mouse bioassay which has been described previously (10, 11) . Briefly, 7-8-wk-old Swiss-Webster mice (Yale colony) were kept at 35°C for 1-2 h until stable temperatures were achieved. They were then injected intravenously with 0.3 ml of a test solution, usually a dilution of superuate from incubated cells, and rectal temperatures were monitored every 10 min for 50 min. Maximum temperature changes from baseline 20 rain after injection were used to determine the pyrogen content of the sample.
Tissue Culture Cell Lines. All cell lines were maintained in 75 cm 2 plastic flasks (Falcon Plastics, Div. BioQuest, Oxnard, Calif.), and incubated in 5% CO2, 95% air. Fresh medium was supplied every 2-3 days; for mouse tumor cell lines, only one-half the volume of supernate was replaced with fresh medium at each time interval.
Mouse tumor cell lines (J-774, PU5-1.8, WEHI-3, P388 D1, RAW-8, and R-8) were obtained from Dr. Peter Ralph, Walker Laboratory, Sloane-Kettering Institute for Cancer Research, Rye, N. Y. The characteristics and origins of these cells have been described previously (12) (13) (14) (15) (16) . Briefly, J 774, PU5-1.8, and P388 D1 cells resemble macrophages or histiocytes; WEHI is a myelomonocytic leukemia cell line; RAW-8 and R-8 cells were derived from mouse lymphomas and resemble lymphocytes. Cells were maintained in RPMI-1640 medium (Grand Island Biological Co., Grand Island, N.Y.) with 10% heat-inactivated, filtered fetal calf serum, 50 U penicillin/ml and 50 ~g streptomycin/ml. For cell transfer, ----2 ml of supernate containing ~ 104 cells were transferred weekly to new incubation flasks with 30 ml fresh medium. Before transfer of J-774, PUS-1.8, or WEHI-3 cells, which grow as loosely adherent cell layers, cells were detached from the flask surface by vigorous pipetting.
For experiments with the histiocytic and myelomonocytic cell lines, flasks of a single line with nearly confluent, adherent cell layers were selected, usually 3-4 days after seeding. All supernatant medium was discarded, and flasks were rinsed four times with RPMI (without serum) warmed to 37°C. 10 ml RPMI with 2.5 mg/ml lactalbumin hydrolysate (ICN Nutritional Biochemicals, Div. International Chemical & Nuclear Corp., Cleveland, Ohio), pyrogen-free (PF) medium, were then added. In some experiments, 10% endotoxin free, heat-inactivated fetal bovine serum (Flow Laboratories, Inc., Rockville, Md.; lot 4055 1190) was used in place of lactalbumin. In other experiments, heat-killed staphylococci, prepared as described previously (11) , were added to one of a pair of flasks at an estimated ratio of 10:1 bacteria to cells. The flasks were incubated for 18 or 42 h. For experiments with R-8 and RAW-8 cells which grow in suspension, 3-4 days after seeding the flask contents were removed, centrifuged at 100 g for 10 min, and the supernatant medium was discarded. The cells were resuspended in RPMI without serum, centrifuged at 100 g for 10 min, and this washing procedure was repeated three times. Cells were finally suspended in 10 ml PF medium and equal aliquots were incubated in new flasks for 18 or 42 h.
Human tumor cell lines (Caki-1, Caki-2, and SK-HEP-1) were obtained from Dr. JSrgen Fogh, also of Walker Laboratory. The characteristics and origins of these lines have been previously reported (17) . Caki-1 and Caki-2 cells, derived from clear cell renal adenocarcinomas, were grown in McCoy's 5 A medium (modified) (Grand Island Biological Co.), containing 15% filtered fetal calf serum, 50 U penicillin/ml, and 50 /~g streptomycin/ml. SK-HEP-1 cells, derived from an adenocarcinoma of the liver, were similarly maintained except that Eagle's minimal essential medium (MEM; Aute-POW, Flow Laboratories, Inc.) plus 2 mM L-glutamine was substituted for McCoy's medium. For transfer of cells, flasks with confluent layers were either treated with Viokase (11) (Grand Island Biological Co.) for Caki-1 and SK-HEP-1 lines, or cells were detached by scraping with a rubber policeman, for Caki-2 cells. One half of the cells recovered from each flask were transferred to new flasks containing 20 ml of the appropriate medium.
For experiments with human tumor cell lines, all supernate was removed from flasks with confluent cell layers, and the cells were rinsed three times with medium containing no serum. Flasks were then reincubated for 18 to 42 h with 5 ml of medium containing 15% pooled normal human serum. 5 ml medium with 15% human serum was also incubated as a control.
3T3-SV 40 mouse fibroblasts (Swiss-Webster origin) were obtained from B. Dorman, Department of Biology, and Dr. Paul Lebowitz, Department of Medicine, Yale University. Cells were grown in MEM (see above) with 2 mM L-glutamine, 10% fetal calf serum, 50 U penicillin, and 50 ~tg streptomycin/ml. Once a week, cells were transferred using Viokase as described above. For experiments, the same techniques were used for rinsing and incubating cell layers as those described for human tumor cell lines, except that 10% rather than 15% serum was used.
At the end of all incubations, supernates were removed, centrifuged at 800 or 2000g for 20 rain, and assayed for pyrogen content. Cells were also removed and counted, using a hemocytometer or Coulter counter (model ZF; Coulter Electronics Inc., Hialeah, Fla.), and viability was measured in most experiments by exclusion of 1% eosin dye. When present, nonadherent cells were collected by initial centrifugation of the supernates at 100 g; adherent cells were obtained by scraping or by treatment with Viokase. For cells incubated with Streptomyces albus, percent phagocytosis was estimated from Wright's-stained coverslip smears. This varied from 59-77% in all experiments.
Heat and Pronase Treatment of Pyrogens. 50 mg of pronase (B-grade; Calbiochem, San Diego, Calif.) was dissolved in 5 ml saline, and preincubated for 2 h at 37°C. 0.05 ml was then added to 2.5 ml of a pyrogenic supernate and the mixture was incubated for 4 h at 37°C. Another 2.5 ml of the pyrogenic supernate was incubated for 3 h at 37°C, and then for 1 h at 56°C. A third aliquot was incubated for 4 h at 37°C with no additions. As a control, 2.5 ml tissue culture medium containing no pyrogen, with 0.05 ml pronase added, was also incubated at 37°C for 4 h.
Assays for lntracellular Pyrogen. Flasks of J-774 cells were chosen 3 or 4 days after cell transfer, and cells were incubated in PF medium for 18 or 42 h, as described above. Supernatant medium was removed for subsequent pyrogen assay, and cell layers were rinsed three times with warmed RPMI medium. 5 ml RPMI was then added to the flask, and the cells were detached with a rubber policeman. In some experiments, this cell suspension was transferred to a duplicate flask and additional cells were collected. Cell numbers in the suspensions, both total and percent viable, were determined as described above. The mixture was disrupted by five cycles of freezethawing in dry ice-acetone, centrifuged at 2,000 g for 20 rain, and the supernate was then assayed for pyrogen content.
Sephadex Filtration ofPyrogenic Supernates. PF medium was added to flasks of J-774 cells as described previously, and after a 48-h incubation, it was removed and stored at -20"C. A pool of 100 ml medium was assayed for pyrogen content and then concentrated to 2.5 ml by evaporation through dialysis tubing in front of a fan. This material was filtered through a 48 x 2.5-cm Sephadex G-75 column, prepared as described previously (18) and equilibrated with phosphatebuffered saline, p H 7.4, containing 2.5 mg/ml lactalbumin hydrolysate. Sodium azide was omitted. 5-ml effluent fractions were collected, and 0.3-ml vol were injected for pyrogen assay. Three experiments with J-774 pyrogen were carried out, using two different columns. Human monocyte pyrogen was also prepared as described previously (18), and 1.5 ml containing four rabbit doses was filtered separately on one of the columns. Where pyrogen assays of individual tubes were carried out at several dilutions, a "derived" (AT) was calculated by taking the average values for peak AT and multiplying by the dilution. Markers to determine exclusion and filtration volumes for different molecular weights included blue dextran, ovalbumin (Worthington Biochemical Corp., Freehold, N. J.), and 2 x crystallized trypsin and ribonuelease A (both from ICN Nutritional Biochemicals). Protein markers were applied singly to each column after completion of the pyrogen studies using buffer containing no lactalbumin, and their filtration volumes were determined by measurement of optical density at 290 h.
Results

Histiocytic and Myelomonocytic Tumor Cell Lines. Supernate from tissue
culture flasks was obtained 24 or 48 h after incubation of the cells in PF culture media, and was tested in mice for pyrogenicity. The results of a representative experiment with J-774 cells are shown in Fig. 1 . Although the supernate removed after 24 h of incubation was only equivocally pyrogenic, supernate from the 48-h incubation clearly produced a febrile response in mice. The shape of the fever curve, which peaked at 20 rain after injection and rapidly returned to baseline or below, is identical to that produced by injection of mouse rnacrophage pyrogen, obtained after stimulation of normal peritoneal macrophages by phagocytosis (10, 11) . Injection of media alone (control) caused no elevation of temperature, When results of a series of experiments were exam- ined, pyrogen was clearly detectable in medium from 24-h incubations, but larger amounts were always present after 48-h incubations. In addition, the same results were obtained when PF media contained fetal bovine serum in place of lactalbumin. These results suggest that J-774 cells spontaneously release pyrogen into the medium during in vitro culture. Similar experiments were carried out with three other mouse cell lines: PU5-1.8 and P 388 D1, which have the characteristics of histiocytic tumors, and WEHI-3, previously characterized as a myelomonocytic leukemia. In each instance, we obtained findings which were essentially identical to those described above for J-774 cells. A summary of our results is shown in Fig. 2 . Pyrogen was present in supernates of 48-h incubations of all four cell lines• We initially tested the culture supernates in a wide range of doses, injecting media derived from 5 x 10L10 s viable cells (complete data not shown). Since subsequent studies showed that maximal temperature elevations in the mice occurred regularly when media representing about 1-5 × 105 cells per dose was injected, this dilution of supernate was then tested most extensively for each cell line.
Lymphocytic Tumor Cell Lines• Spontaneous pyrogen release during in
vitro culture was demonstrated in similar experiments using cells from one of two mouse cell lines previously characterized as closely resembling lymphocytic lymphoma cells (Fig. 3) . Unlike the results with the macrophage lines discussed above, pyrogen in the PF culture medium of RAW-8 cells was more easily detectable after 24 h than after 48 h incubation• However, maximal fevers were produced as before by dosages of supernate corresponding to 1-5 × 105 cells/ dose. We were unable to demonstrate any pyrogen release at either 24 or 48 h into PF media by the other lymphocytic tumor line, R-8, although doses of supernate corresponding to 10L10 s viable cells were examined. Cells. We studied the effect ofphagocytosis of staphylococci on pyrogen release by two histocytic cell lines, J-774 and PU5-1.8. In both cases, we noted increased fevers in the mice after injection of supernates from cells stimulated by ingestion of bacteria compared to the same numbers of cells releasing pyrogen spontaneously in culture (Fig. 4) . Although the mouse assay for pyrogen is not quantitative over a large dose range, it is roughly quantitative over a two-to three-fold range between minimal and maximal temperature elevation, when increasing amounts of pyrogen are injected (10). These results, therefore, suggest that there were small, probably one-to twofold, increases in the amounts of pyrogen released by these cells after particle ingestion. We did not study either of the lymphocyte-like lines after incubation with staphylococci since we presumed they were nonphagocytic; R 8 cells do not ingest bacillus Calmette-Gu~rin (BCG) (19) . Characteristics of Tumor Cell Pyrogens. As is illustrated in Fig. 1 , the type of febrile response induced by the pyrogens from all five of these cell lines was identical to that produced in mice by normal leukocyte EP (10, 20) . The pyrogens in flask supernates of the mouse tumor cells appeared to be more stable than those present in crude supernates of stimulated mouse macrophages, since they lost little activity during storage at -20°C for 1 wk, or -70°C for over 3 wk, whereas mouse macrophage pyrogen loses activity within days at 4°C and within 1 wk at -70°C (unpublished observations). However, the tumor cell pyrogens were inactivated by heating to 56°C for 1 h, and by incubation with pronase (Fig. 5 ). These characteristics suggest that they are proteins, like other endogenous pyrogens of leukocyte origin (7). We obtained an estimate of the molecular weight of the pyrogen released by J-774 cells by filtration of a concentrate of culture supernate through a Sephadex G-75 column (Fig. 6) . Two peaks of pyrogenic activity were present, one at a mol wt of = 30,000, and the other at a mol wt ___60,000, close to the exclusion volume of the column. Because the pyrogen assay in mice is not easy to quantitate, it is not certain how much of the total pyrogenic activity was associated with each peak. However, the amounts appeared to be similar. By contrast, when supernate from human monocytes was applied to the same column, the two expected peaks of activity were noted, at mol wt of ~ 14,000 and 40,000, and the quantity of the 14,000 tool wt pyrogenic species was clearly greater, as reported previously (18). nates were assayed for progen content, at no time were significant amounts of intracellular pyrogen detected (Table I) , even though pyrogen was present in the culture supernates of the same cells (positive assay results are underlined). The character of the PF medium in which cells were cultured to collect pyrogen for assay did not appear to affect pyrogen production, since we obtained identical results using medium containing either lactalbumin hydrolysate or a PF bovine serum. These findings, therefore, suggest that active production and secretion of pyrogen by these cells is occurring spontaneously and continuously during in vitro culture. Table II * Average change in temperature from baseline 20 min aRer injection, ± SEM. $ Cells from which supernate was derived for injection. § Injection of medium alone. II Number of injections. ¶ ND, not determined.
Effect of Phagocytic Stimulation on Pyrogen Release by Histiocytic Tumor
Mechanism of Production of Tumor Cell
Comparison of Pyrogen Production with Other Characteristics of Mouse Tumor Cell Lines. As shown in
Studies of Pyrogen Release by Human Carcinoma Tumor Cell Lines and Viral-Transformed Mouse Fibroblasts.
Since patients with tumors other than leukemias and lymphomas occasionally suffer from prolonged, unexplained fevers, we also studied the capacity for pyrogen production by cells from three tumor cell lines derived from human carcinomas, two renal cell carcinomas (CAKI-1 and CAKI-2), and one hepatoma (SK-HEP-1) . In addition, we tested 
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Histiocytic, loosely methylcholanadherent threne-induced lymphoid tumor, ascites form (12) Balb/c cloned from a Monocytic, Ib~sely admyelomonocytic herent, differenleukemia (14) tiates into granulocytic and monocytic colonies ( produce pyrogen only af~er stimulation with an exogenous agent, such as endotoxin or phagocytosis, and production of pyrogen ceases after 1-2 days (7). In the studies reported here, we have demonstrated that three mouse tumor cell lines with characteristics of macrophage or histiocytic tumors, and one identified as a myelomonocytic leukemia, release pyrogen during in vitro culture. Moreover, this release appears to occur spontaneously and continuously during cell growth and multiplication. This conclusion is supported by our data showing that increasing amounts of pyrogen relative to cell numbers appear in the culture media with time, that similar amounts of pyrogen are produced by cells chosen either 3, 4, or 5 days after seeding, and that pyrogen accumulates in culture media which is identical to standard growth media except for the absence of endotoxin. Thus, these tumor cells appear to have retained the capability to produce pyrogen that is characteristic of their nonmalignant cells of origin, but to have acquired an altered mechanism for production of pyrogen, since they apparently require no initiating stimulus, and production does not cease after 24-48 h.
In preliminary studies, we have determined that production and secretion of the tumor cell pyrogens is an active, energy-requiring process. Cells kept at 4°C failed to release pyrogen. At no time were we able to detect significant levels of intracellular pyrogen in the one cell line examined, even though pyrogen was present in increasing amounts in the extracellular medium. Small but significant increases in pyrogen production occurred after incubation of cells from two histiocytic tumor lines with staphylococci, during which time most cells ingested bacteria. These results are similar to those obtained in studies of pyrogen synthesis and release by normal granulocytes and monocytes (7), indicating that the tumor cells retain some of the properties associated with pyrogen production of their cells of origin. On the other hand, as noted above, they appear to have lost at least a part of the normal control mechanisms for initiation and cessation of transcription of the pyrogen molecule, presumably a gene-mediated function (26, 27) .
The pyrogens released by these tumor cell lines appear similar to the endogenous pyrogens that are produced when normal phagocytic cells of bone marrow origin are stimulated by phagocytosis or other inflammatory agents. Pyrogen produced by the macrephage tumor lines J-774 and PU5-1.8 were inactivated by heating at 56°C for 1 h and by a 4-h incubation with pronase. All pyrogens produced febrile responses characteristic of EP in mice, as illustrated in Fig. 1 . These properties are the same as those of endogenous pyrogens derived from normal human (20) , rabbit (P. Bodel, unpublished observations) and mouse (10) granulocytes, monocytes, or macrophages. The estimated molecular weights of pyrogens produced by J-774 cells were, however, larger than those reported for all other endogenous pyrogens previously studied, including those produced by granulocytes, monocytes, and macrophages of human or rabbit origin (18, (28) (29) (30) . We have not yet determined the molecular weight of mouse macrophage pyrogen because of the lability of the molecule; possibly, pyrogens from mouse leukocytes will also prove to be of unusual size. Alternatively, pyrogenic molecules produced by tumor cells may have different physico-chemical characteristics from pyrogens produced by their nonmalignant cells of origin.
When tumor lines of carcinomas or viral-transformed fibroblasts were studied, we failed to detect any pyrogen in culture supernates. Thus, although many carcinomas are associated with unexplained fever in occasional patients, our studies do not provide support for the hypothesis that such tumor cells can produce pyrogen. These data extend our previous observations that HeLa cells and fibroblasts did not produce pyrogen, even after ingestion of particles (11) . Possibly, fever in patients that is associated with the growth of carcinomas is a result of host cell interactions with the tumor, producing stimulation of host granulocytes, monocytes, or macrophages to produce pyrogen, rather than the result of the release of pyrogen by the tumor cells themselves.
The same cell lines that released pyrogen in our studies have been shown by others to secrete lysozyme, and in all but one instance (RAW-8), to have other macrophage characteristics, detailed in Table II . Two of the cell lines produce colony-stimulating activity (CSA), either spontaneously (19) , or after addition of agents such as lipopolysaccharide (LPS) or zymosan (25) . Lymphocyteactivating factor (LAF) is produced by all four macrophage tumor cell lines, after stimulation by LPS (24) . It is noteworthy that tumor cells of presumed Blymphocyte origin (R-8) did not produce pyrogen in our experiments. Normal lymphocytes have never been found to produce pyrogen, even after antigenic or blastogenic stimulation (7).
Our results raise the possibility that tumor-associated fever in patients with certain malignancies, such as some acute leukemias and lymphomas, may be due to the production of endogenous pyrogen by the malignant cells of granulocytic or monocytic origin. By extrapolation from studies of the cell lines WEHI-3 and RAW-8, it seems likely that the pyrogen molecules can be produced by immature cells at a stage of maturation preceding differentiation into granulocytes or monocytes. The hypothesis that malignant granulocytes and macrophages release pyrogen spontaneously during growth would be consistent with the observation that tumor-associated fever occurs in patients with these diseases during relapse, or at times of disease activity, but not during remissions (1-3). Preliminary studies have also shown that the human histiocytic tumor cell line, U-937 (16) , also releases pyrogen during in vitro culture (P. Bodel and P. Ralph, unpublished observations). Such cells may provide an easily available source of human EP for laboratory investigations. Summary Tumor-associated fever occurs commonly in acute leukemias and lymphomas. We investigated the capacity for in vitro production of pyrogen by three mouse histiocytic lymphoma cell lines (J-774, PU5-1.8, p 388 D1), one myelomonocytic line (WEHI-3), and two lymphoma-derived lines, RAW-8 and R-8. Pyrogen was released spontaneously into the culture medium during growth by all cell lines with macrophage or myeloid characteristics including lysozyme production; R-8 cells, of presumed B-lymphocyte origin, did not produce pyrogen. When injected into mice, the pyrogens gave fever curves typical of endogenous pyrogen, were inactivated by heating to 56°C and by pronase digestion, and appeared to be secreted continuously by viable cells. Two pyrogenic molecular species produced by J-774 cells were identified by Sephadex filtration, one of mol wt ~ 30,000, and the other ___60,000. By contrast, three carcinoma cell lines of human origin and SV-40 3T3 mouse fibroblasts did not produce pyrogen in vitro. These results suggest that some malignant cells derived from phagocytic cells of bone marrow origin retain their capacity for pyrogen production, and may spontaneously secrete pyrogen during growth.
